Evidence map›Paper›PMID 33319329›Full record

ArticlePharmaceutical research2020

Peptide Isolation via Spray Drying: Particle Formation, Process Design and Implementation for the Production of Spray Dried Glucagon.

Frederik J S Doerr, Lee J Burns, Becky Lee, Jeremy Hinds, Rebecca L Davis-Harrison, Scott A Frank, Alastair J Florence

Open access · hybridAbstract read
In one paragraph

Article in Pharmaceutical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Frederik J S DoerrEPSRC CMAC Future Manufacturing Research Hub, Technology and Innovation Centre, 99 George Street, Glasgow, G1 1RD, UK.
Lee J BurnsSmall Molecule Design and Development, Eli Lilly and Company, Indianapolis, IN, 46221, USA.
Becky LeeEurofins Lancaster Laboratories PSS, Indianapolis, IN, 46221, USA.
Jeremy HindsSmall Molecule Design and Development, Eli Lilly and Company, Indianapolis, IN, 46221, USA.
Rebecca L Davis-HarrisonSmall Molecule Design and Development, Eli Lilly and Company, Indianapolis, IN, 46221, USA.
Scott A FrankSmall Molecule Design and Development, Eli Lilly and Company, Indianapolis, IN, 46221, USA.
Alastair J FlorenceEPSRC CMAC Future Manufacturing Research Hub, Technology and Innovation Centre, 99 George Street, Glasgow, G1 1RD, UK. alastair.florence@strath.ac.uk.
Eli Lilly (United States) · USUniversity of Strathclyde · GB

Funding

Engineering and Physical Sciences Research Council EP/K503289/1Engineering and Physical Sciences Research Council EP/P006965/1Higher Education Funding Council for England HH13054
6 · The paper itself

Abstract

purposeSpray drying plays an important role in the pharmaceutical industry for product development of sensitive bio-pharmaceutical formulations. Process design, implementation and optimisation require in-depth knowledge of process-product interactions. Here, an integrated approach for the rapid, early-stage spray drying process development of trehalose and glucagon on lab-scale is presented.

methodsSingle droplet drying experiments were used to investigate the particle formation process. Process implementation was supported using in-line process analytical technology within a data acquisition framework recording temperature, humidity, pressure and feed rate. During process implementation, off-line product characterisation provided additional information on key product properties related to residual moisture, solid state structure, particle size/morphology and peptide fibrillation/degradation.

resultsA psychrometric process model allowed the identification of feasible operating conditions for spray drying trehalose, achieving high yields of up to 84.67%, and significantly reduced levels of residual moisture and particle agglomeration compared to product obtained during non-optimal drying. The process was further translated to produce powders of glucagon and glucagon-trehalose formulations with yields of >83.24%. Extensive peptide aggregation or degradation was not observed.

conclusionsThe presented data-driven process development concept can be applied to address future isolation problems on lab-scale and facilitate a systematic implementation of spray drying for the manufacturing of sensitive bio-pharmaceutical formulations.

Indexed as

Technology, PharmaceuticalDrug StabilityExcipientsFreeze DryingGlucagonPowdersProtein AggregatesProtein StabilityTrehaloseExcipientsGlucagonPowdersProtein AggregatesTrehalosedroplet dryingpeptide formulationprocess developmentpsychrometric process modelspray drying

Identifiers

PMID33319329
PMCPMC7736029
OpenAlexW3091754402

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.